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reported that to increase the diagnostic accuracy of the AUS/FLUS FNA category and to prevent unnecessary surgery, two approaches have been proposed. The recommended management is clinical correlation and a repeated FNA at an appropriate interval. [1] [2] [3] In some cases, the physician may choose not to repeat the FNA but to observe the nodule clinically or, alternatively, to refer the patient for surgery because of concerning clinical and/or sonographic features. 1 Thus, determination of sonographic features associated for surgery or observation is important.
In their published article in the Annals of Surgical Oncology, Nagarkatti et al. 4 reported that younger and male patients with Bethesda criteria for AUS/FLUS were more likely to go directly to surgery. They reported that ultrasound features such as micro-calcifications, irregular margins, and marked hypoechogenicity did not appear to influence the decision to observe the patients or refer them for surgery. The choice of surgery versus observation was primarily based on the patient's gender, the clinical judgment of the endocrinologist and/or surgeon, and the patient's preference. 4 However, Nagarkatti et al. 4 did not report the predictor factors for malignancy, which are important in differentiation for surgery or observation.
In our series, among all the thyroid FNAs performed during the study period between 2011 and 2015 at our institution, 11.3% (370 of 3270) resulted in AUS/FLUS. Of the 370 patients classified as AUS/FLUS on the initial FNA, 137 underwent surgery and 233 did not undergo surgery. The percentage of patients who were young (\ 45 years) and had a nodule size of 2 cm or larger was significantly higher among those who underwent surgery than among those who did not.
Among the 137 patients who underwent surgery, the predictor factors for malignancy were microcalcifications, nodule smaller than 2 cm, solid structure, hypoechogenicity, irregular margin, and increased vascularity of the nodules. We found that sonographic features did not influence the choice for surgery. The causes for selection of older patients for observation could be comorbidity, patient preference, physician life expectancy or other reasons. However, nodule size smaller than 2 cm should not be a criterion for observation of patients with AUS//FLUS FNA. We support the findings of Nagarkatti et al. 4 who reported that sonographic features of nodules did not influence the choice for surgery or observation, but that age significantly influenced the choice. We suggest that worrisome sonographic predictors of malignancy in patients with AUS/ FLUS FNA should be considered for surgery.
